Related Experiment Video
Updated: Jun 19, 2026

09:46
Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
Published on: January 20, 2023
STUDIES ON ORGANOGENESIS : I. THE ABILITY OF ISOLATED BLOOD CELLS TO FORM ORGANIZED VESSELS IN VITRO
1Laboratories of The Rockefeller Institute for Medical Research.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Isolated blood cells in plasma can form organized tubular structures. Red cells initiate formation, while leukocytes and thrombocytes build the walls, dependent on plasma coagulation timing.
Area of Science:
- Hematology
- Cell Biology
- Biophysics
Background:
- Blood cells exhibit complex behaviors when cultured in vitro.
- Plasma serves as a critical biological medium influencing cellular interactions.
Purpose of the Study:
- To investigate the capacity of isolated blood cells to form organized structures in a plasma medium.
- To elucidate the cellular and environmental factors governing the formation of these tubular structures.
Main Methods:
- Incubation of isolated blood cells within a plasma substratum.
- Observation and analysis of cellular interactions and structure formation.
- Manipulation of plasma coagulation time and addition of specific substances.
Main Results:
- Blood cells spontaneously constructed highly organized tubular processes in a plasma medium.
- Red blood cells initiated tubule formation, with leukocytes and thrombocytes contributing to wall construction.
- Tubule development was dependent on a slightly delayed plasma coagulation; firm coagulation halted further growth.
Conclusions:
- Blood cell-derived tubular structures form through a sequential, ordered process.
- Plasma's physicochemical properties and coagulation dynamics are crucial for this phenomenon.
- Cellular interactions, particularly involving red cells, leukocytes, and thrombocytes, drive the formation of these organized structures.
Related Concept Videos
Development of Blood Vessels
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

